NAD-related biology is connected to the body’s daily rhythms, but that does not tell us whether a supplement will improve insomnia. The useful question is what happened to sleep in controlled human studies.
Small NMN trials in older adults offer preliminary findings. They do not establish NAD injections as a sleep treatment, or a universal rule that everyone should take a precursor in the morning or evening.
Sleep findings are preliminary and product-specific. Persistent insomnia deserves its own assessment and treatment plan.
What did the 2022 timing study compare?
A 12-week trial in 108 older Japanese adults compared NMN with placebo, each taken in morning or afternoon groups. Sleep was assessed using a questionnaire, alongside fatigue and physical function. Some changes also occurred in placebo groups, including improvement in afternoon-group drowsiness. A favorable change from a group’s own starting point therefore should not be read as proof that NMN outperformed placebo on every sleep measure.
What did the 2024 study add?
A separate trial of 60 older adults reported better sleep-questionnaire results on selected secondary outcomes after 12 weeks of NMN. Its primary stepping-test outcome did not differ significantly between groups. Secondary sleep findings can help shape future studies, but the trial did not establish a treatment for diagnosed insomnia or sleep apnea. Its size, duration, and manufacturer involvement belong in the interpretation.
Does this establish the best time to take NAD?
No. An afternoon NMN study cannot determine the timing of a different NR blend, direct-NAD liquid, or prescription injection. Follow the instructions for the actual product and discuss unwanted sleep changes with the treating professional. Read timing and frequency questions for the difference between label instructions and a universal “NAD protocol.”
Read beyond the NAD ingredient
A formula may include coffee-fruit caffeine, other vitamins, or several botanical ingredients. For example, the Qualia review identifies caffeine on its checked label. If sleep changes after starting a blend, the NAD-related ingredient is not automatically the cause. Keep the full label and a simple record of timing, symptoms, and other changes so the discussion is about the product actually used.
What has stronger support for chronic insomnia?
The National Heart, Lung, and Blood Institute describes cognitive behavioral therapy for insomnia, or CBT-I, as a usual first treatment for long-term insomnia. It is a structured treatment, not simply a recommendation to “sleep better.” A sleep assessment can also clarify whether medicines or another sleep disorder need attention. An NAD blood test does not diagnose the cause of poor sleep.
A useful question before spending money
Ask what would count as a meaningful improvement, how long the evaluation would last, and what happens if nothing changes. Avoid buying a long subscription based only on a cellular-energy explanation. The before-and-after guide and NAD testing guide can help separate a symptom outcome from a biomarker story.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- NMN timing, sleep, and fatigue randomized trial (2022) 108 older adults; morning/afternoon NMN and placebo groups, with changes also seen in placebo groups.
- Morifuji et al. (2024): NMN, walking, and secondary sleep outcomes 60 participants; primary stepping outcome did not differ. Sleep findings were secondary; manufacturer involvement.
- NHLBI: insomnia treatment Describes CBT-I as a usual first treatment for long-term insomnia; not evidence for NAD supplements.
- Qualia: NAD+ product page Manufacturer product and study claims; consult the current label and exact study design.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.